>PROKKA_00001 putative protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain
MKSKLLKTIALTLISVNTIVYPIYAAEVPKFSNLNDVEENIYTHLINRDSNINFIYTGST
REFKDNIVKTIKAAYSKDDYTERSWLEIKSNVNISDGKINTSINIEYLTNKEQEEFIDIE
IKKITDKLINDKMSDFEKVKAINDYLANRYEYDYTLSSSNVYSALITNYTVCQGYSLTAY
KMLKNAGIESRIGVGTNKGASHSWNIVKIEDSWYHLDITNNDSTRSNKYFLVSDKFLEDN
NYKWNRTEYPEALNNK*
>PROKKA_00002 hypothetical protein
MFSKAFGFIFKAIISFVVLIVSIKFLWVSILIFIDRVVNIFNIIG*
>PROKKA_00003 hypothetical protein
MGNKKANLNGSLYWNVVPVSFRKEDTFMTLPGHSQILNNLYKENDHGYVAIFRKGFKGIY
QRHYKKQDLEEALDVFFSGGYNNELYISMNTFLKPNRTSENLRYLNALYIDIDCYKLNIR
KESVLFFLENDFYNKIIPEPSVVVDSGRGLYLVWFIEPVPSRALTLWRAMQYYLYSALKE
FGADRAALDESRVLRVVGSYNSKSDSYVKIVDFNNFRYTLKDLKSEYLPEIKKEDKKIKK
KRKSNKIHIFNFYGLHKSRMEDIYKLVQLRSYDMKGKRELILFLYRYYATLVEGETVAEE
MTLELNESFIEPLPLNEINSTKSNYIGKYNYKNKTLVELLEISLEEMKHMTSLISKEHKF
QRNNERRKGLRRNENGLTKREQLKKDNLIKIIKLMDEGRKTKEIAETLDISLRMVQKYKK
ELKENNKLYEDLKKEILSINDNYNEDEIQCYDIDLNLEEIEEIFNDDLKKVGS*
>PROKKA_00004 hypothetical protein
MKKTKIEIRLTEVQKEDIKLRAKNKSLKMSEYILNKIYENPESTNDIKDLLRFNIKELLR
LKVEYLNQKKECDDANKNKKIENKLVDLDKIITTLTAMLNDEEFNF*
>PROKKA_00005 Putative DNA-invertase from lambdoid prophage Rac
MIYGYVRVNTKEQLNNNSIEKQIFEIFDVYSNAIIYEETFNNKFTVRPKFLELLDLLNKH
DILVVTELDKFCTSIKEGLKYIKMLINNGVKVHILNMGMIENTSIGNLIIKNLIAFDKFE
EMILKQYSKNKDGRPKKFTLIQLRYALSLLKVNGGKNSYNEVARITGISKSTLIREMKKC
HEKLD*
>PROKKA_00006 Transposon Tn3 resolvase
MIFGYMRISTNKEKQKTDRQEITLINYSKENNFTFGDIVPEKISGSVKANYRPKYKSLKE
KLRSNDILIITDVDRLGRDADDIIMEFKNLKASGIRIIPLDVPYLNQWKNVKDDSMYNMI
SDIYITIKAHQAQQEKEKIVARINQGLDAAKAKGTKLGRPSVKIDPNFIREYTKFKNGIY
GDITATNFAKMLGIGRSTLYKYIKILKNQE*
>PROKKA_00007 Botulinum neurotoxin type B precursor
MPVTINNFNYNDPIDNDNIIMMEPPFARGTGRYYKAFKITDRIWIIPERYTFGYKPEDFN
KSSGIFNRDVCEYYDPDYLNTNDKKNIFLQTMIKLFNRIKSKPLGEKLLEMIINGIPYLG
DRRVPLEEFNTNIASVTVNKLISNPGEVEQKKGIFANLIIFGPGPVLNENETIDIGIQNH
FASREGFGGIMQMKFCPEYVSVFNNVQENKGASIFNRRGYFSDPALILMHELIHVLHGLY
GIKVDDLPIVPNEKKFFMQSTDTIQAEELYTFGGQDPSIISPSTDKSIYDKVLQNFRGIV
DRLNKVLVCISDPNININIYKNKFKDKYKFVEDSEGKYSIDVESFNKLYKSLMFGFTEIN
IAENYKIKTRASYFSDSLPPVKIKNLLDNEIYTIEEGFNISDKNMGKEYRGQNKAINKQA
YEEISKEHLAVYKIQMCKSVKVPGICIDVDNENLFFIADKNSFSDDLSKNERVEYNTQNN
YIGNDFPINELILDTDLISKIELPSENTESLTDFNVDVPVYEKQPAIKKVFTDENTIFQY
LYSQTFPLNIRDISLTSSFDDALLVSSKVYSFFSMDYIKTANKVVEAGLFAGWVKQIVDD
FVIEANKSSTMDKIADISLIVPYIGLALNVGNETAKGNFESAFEIAGSSILLEFIPELLI
PVVGVFLLESYIDNKNKIIKTIDNALTKRVEKWIDMYGLIVAQWLSTVNTQFYTIKEGMY
KALNYQAQALEEIIKYKYNIYSEEEKSNININFNDINSKLNDGINQAMDNINDFINECSI
SYLMKKMIPLAVKKLLDFDNTLKKNLLNYIDENKLYLIGSVEDEKSKVDKYLKTIIPFDL
STYTNNEILIKIFNKYNSEILNNIILNLRYRDNNLIDLSGYGAKVEVYDGVKLNDKNQFK
LTGSADSKIRVTQNQNIIFNSMFLDFSVSFWIRIPKYRNDDIQNYIHNEYTIINCMKNNS
GWKISIRGNRIIWTLIDINGKTKSVFFEYNIREDISEYINRWFFVTITNDLDNAKIYING
MLESNMNIKDIGEVIVNGEITFKLDGDVDRTQFIWMKYFSIFNTQLNQSNIKEIYKIQSY
SEYLKDFWGNPLMYNKEYYMFNAGNKNSYIKLVKDSPVGEMLIRSKYNQNSNYINYRNLY
IGEKFIIRRKSNSQSINDDIVRKEDYIHLDFVNSNEEWRVYAYKNFKEQEQKLFLSIIYD
SNDFSQTIQIKEYDEQPTYSCQLLFKKDEESTGEMGLIGIHRFYESGVLPKKYKDYFCIS
KWYLKEVKRKPYNSNLGCNWQFIPKDEGWTE*
>PROKKA_00008 Botulinum neurotoxin type A precursor
MYVEINLGEWLNMNINDNLSINSPVDNKNVVVVRARKTDTIFKAFKVAPNIWVAPERYYG
ESLSIDEEYKVDGGIYDSNFLSQDSEKDKFLQAIITLLKRINSTNAGEKLLSLISTAIPF
PYGYIGGGYYAPNMITFGSAPKSNKKLNSLISSTIPFPYAGYRETNYLSSEDNKNFYASN
IVIFGPGSNIVENNTVFYKKEDAENGMGTMTEIWFQPFLTYKYDQFYIDPAIELMKCLIK
SLYFLYGIKPSDDLVVPYRLRNELENIEYSQLNIVDLLVSGGIDPKFINTDPYWFIDNYF
SNAKKVFEDHRNIYKTEVEGNNAIGNDIKLRLKQKFRINTNDIWELNLNYFSKEFSIMMP
DRFNNALKHFYRKQYYKIDYPENYSINGFVNGQINAQLFLSDRNQDIINKPEEIINLLNG
NNVSLMRSNIYGDGLKSTVDNFYSNYKIPYNRAYEYHFNNSNDSSLDNVNTGVIDNIPEI
IDVNPYKENCDKFSPVQKITSTREINTNIPWPINYLQAQNTNNERFSLSSDFVEVVSSKD
KSLVYSFLSNVMFYLDSIKDNSPIDTDKEYYLWLREIFRNYSFDITATQEINTNCGINKV
VAWFGKALNILNTSDSFVEEFQNLGPSSLINKKENLSMPIIEIDEIPNYMLGLPLNDLNE
KLFNIYLKNILYFKKVYFNFLDQWWTEYYSQYFDLICMAKQSILAQEKLIKQIIQNKLQD
LSKADISMDKLNLMNLATGKTFIDLSNESQIAIDNINDFLNKSAICFFDTNIYPKFISFM
EQCINSVNSNVTTFIQKCTNITEDEKLQLIKLNTFMNIDFEFFDIQNIKDLITSETDLIK
EEKESDYNLFLLTLQEDNNKVIEDISGKNTLVKYSDSISLVYGVNGDALYLKEPNESVSF
SNKVFENGLTNSFSICFWLRNLGEDIITSKLIENKADNCGWEIYFENNGLVFSIVDCNGN
EENIYLSDVISKNWYYISISIDRLRNQLLIFINDKLIANQSIEQILNIYSSSTISLVNEN
NPIYVEGLSILNRSITSEEVVNNYFSYLNNSYIRDISGERLEYNKTYELYNYVFPENSLY
EVTENNNIYLSIKDTNDLNIQGAKFKLINIDTNKQYVQKWDEGVVCLLGDEEKYVDISSE
NNRIQLVSSRDTAKKIIFNNDIFKPNCLTFAYNNKYLSLSFRDRNYNWMIYNNNDNIPKA
AHLWTLKGI*
>PROKKA_00009 transcriptional regulator BotR, P-21
MNKLFLQIKRLKNDNREFQEIFKNFEKTIDIFTRKYNIYDNYNDILYHLWYTLKKVDLSN
FNTQNDLERYISRTLKRYCLDICNKRKIDKKIIYNSEIVGEKLRLIANSYSSYSEVEFND
LISILPDDQKKIIYMKFVEDIKEIDIAKKLNISRQSVYKNKIMALGRLKPILVYIFKKF*
>PROKKA_00010 hypothetical protein
MEHYSVIQNSLNDEIVTISCKADTNLFFYQTVGNVSLFQQTRNYLERWRLIYDANKAAYK
IKSMDIHNTNLVLTWNAPTHNISAQQDSNADNQYWLLLKDIGSNSFIIASYKNPNLVLYA
DTVAHNLKLSTLNNSSYIKFIIEDYIISDFNNFTCKISPILDLSKVVQQVAMTDLSVNLY
TWDYGRNQKWTIRYNKEKSAYQFFNTILSNGVLTWISSNGNTVRVSSSAQNNDAQYWLIN
PVSNAYETYTITNLHDTTKALDLYNSQTANGTTIQVFNYHGDDNQKWSIRNP*
>PROKKA_00011 HA 17 kDa subunit
MSVERTFLPDGNYNIKSIFSGSLYLNPVSGSLTFSSESSANNQKWNVEYMAKNRCFKISN
VAEPNKYLSYDNFGFISLDSLSNKCYWFPIKIAVNTYIMLNLNKVNELDYAWDIYDTNEN
ILSQPLLLLPNFDIYNSNQMLKLEKI*
>PROKKA_00012 Hemagglutinin components HA-22/23/53 precursor
MNSSIKKIYNHIQEKVINYSDTIDLADGNYVVSRGDGWILSRQNQILGGSVISNGSTGIV
GDLRVNDNAIPYYYPTPSFNEEYIKNNIQTVFTNFTEANQIPIGFEFSKTAPSNKNLYMY
LQYTYIRYEIIKVLQHEIIERAVLYVPSLGYVKSIEFNPGEKINKDFYFLTNDKCILNEQ
FLYKKILETTKNIPTNNIFNSKVSSTQRVLPYSNGLYVINKGDGYIRTNDKDLIGTLLIE
AGSSGSIIQPRLRNTTRPLFTTSNNAKFSQQYTEERLKDAFNVQLFNTSTSLFKFVEEAP
SNKNICIKAYNTYEKYELIDYQNGSIINTAEYYLPSLGYCEVTNAPSPESEVVKTQVAED
GFIQNGPEEEIVVGVIDPSENIQEINTAISDNYTYSIPDIVDNNPFYILFTVNTTGIYKI
NAQNNLPPLKIYEAIGSGNRNLQSGNLCNDHIKAINYITGFDSSNAKSYLVVLLNKNKNY
YIRVPQTSSNIENQIKFKREEGNIRNLANSSVNIIDNLNSTGEHYYTRQSPDVGNYISYE
FTVPGNFNNKDTSNIRLYTSNNQGIGTLFRVTETIDGYDLIDIQQNLHLLNSTKSIRLLN
GAIYILKVEVTELNNYNIRLHIDITN*
>PROKKA_00013 hypothetical protein
MKFDSSASDNIRAIWAFTFALMQASFYDNGNHPKMLIENFKL*
>PROKKA_00014 hypothetical protein
MLKENDRLGLLTLIRKENHKWRTYWYYKCDCGNEKWIRADALNRTKKPTRSCGCLAENTQ
FKKEDITNERFGKLQAIRPTEQKRGNSTVY*
>PROKKA_00015 hypothetical protein
MKGKVTFNISGSGSKSARLTIPAALIELMKITEDNREVEITYEDGKLVVEKVSEYVEGK*
>PROKKA_00016 hypothetical protein
MNAKGHEVDYDEEEVEILDAEGCENECEVLIHKDTQKFIITFVSTDEDFEEMRYYER*
>PROKKA_00017 hypothetical protein
MYNLINSLSNGDQKMFWLIFDLIVIATFHLIWFSYLFFKRKDSEL*
>PROKKA_00018 Modification methylase MboII
LWDAATPYVDWTNNGGEKMLDINQIYNMDCRAGLKLLDDNSIDCCITFPPYWGLRDYGVD
GQIGLEETLQDYLKEMVEVFREVKRILKPEGTLWLNLGDSYVGTGGNRKNEVKNKIFNQQ
QSHNPKNGRYERIKKIKEDGLKPKDLMGIPWRVAFALQEDGWYLRSDIIWNKTNCMPEAV
KDRPTKAHEYIFLLSKSNRYYYDNESIKEDCVNGDPNPPRGSKGVLGNLNKGRRLKGNSK
TFRGGGAYTQNRCFDNSADVERESHGNKPNLLMKRNKRTVWNVATDSFKEAHFATFPPKL
IEPCVIAGCPEGGIILDVFMGSGTTGMVAIKNNRNYIGFELNHDYVEIANKYRLNEVQLK
IV*
>PROKKA_00019 hypothetical protein
MIKKLSGILILGVLILTFTGCGLLNKVNMSEKVNTSEETKDMTIFDSKVITDEKDKKFKI
LSNEKQEFGTLTIIKYKETGEKFVIFSGYNNGGIAKPD*
>PROKKA_00020 hypothetical protein
MLISVLIAAIPIFLILNRNYIYKAKLFESIKGVIKYAMFLSILFFIGFFVGNCNTILEIF
K*
>PROKKA_00021 hypothetical protein
MKINMNKTIKIKLTNRGKMILFEYWEKSFKKHNLEDVIEWVNTNIESTKVIL*
>PROKKA_00022 hypothetical protein
MSIILISELMTKLNSNSFNREQLNIIEEYNNKDKKLFLITICIVFASSIFDSIFRINLIF
EIVDTVSIISAMLILIRYLYFKLTMKKSLLIELQEIENKKVKIV*
>PROKKA_00023 hypothetical protein
MKILIDEKQYLEVMKLLNIITRENKKYLSLMKQLDKSKKNNIRKRLIAAVEKWVECEVTG
DEAMAQIIELLEIKLTN*
>PROKKA_00024 hypothetical protein
MNMPTMQELTQIWEVIIIWIKYMLMHLAIAMPIMFIVMKFLNVNKKFAKLLK*
>PROKKA_00025 hypothetical protein
MNIWISVTKDKEIKKIYYDFNKQIKELDIRRLKVEYEVIYNIYKYSKELEDSNNESTNNI
ENIIKWINIIDVNSLEELENALDEQIRYSL*
